BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 6306422)

  • 1. Role of deoxycytidine kinase in the inhibitory activity of 5-substituted 2'-deoxycytidines and cytosine arabinosides on tumor cell growth.
    Balzarini J; De Clercq E
    Mol Pharmacol; 1983 Jan; 23(1):175-81. PubMed ID: 6306422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential affinities of pyrimidine nucleoside analogues for deoxythymidine and deoxycytidine kinase determine their incorporation into murine leukemia L1210 cells.
    Balzarini J; De Clercq E
    Acta Biochim Pol; 1987; 34(2):63-77. PubMed ID: 2823514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral, antimetabolic, and cytotoxic activities of 5-substituted 2'-deoxycytidines.
    De Clercq E; Balzarini J; Descamps J; Huang GF; Torrence PF; Bergstrom DE; Jones AS; Serafinowski P; Verhelst G; Walker RT
    Mol Pharmacol; 1982 Jan; 21(1):217-23. PubMed ID: 7132959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incorporation of 5-substituted pyrimidine nucleoside analogues into DNA of a thymidylate synthetase-deficient murine FM3A carcinoma cell line.
    Balzarini J; De Clercq E; Ayusawa D; Seno T
    Methods Find Exp Clin Pharmacol; 1985 Jan; 7(1):19-28. PubMed ID: 3990443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2',3'-Dideoxycytidine: regulation of its metabolism and anti-retroviral potency by natural pyrimidine nucleosides and by inhibitors of pyrimidine nucleotide synthesis.
    Balzarini J; Cooney DA; Dalal M; Kang GJ; Cupp JE; DeClercq E; Broder S; Johns DG
    Mol Pharmacol; 1987 Dec; 32(6):798-806. PubMed ID: 2826994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism and chemotherapeutic activity of 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia L1210 and evidence for its phosphorylation by deoxycytidine kinase.
    Brockman RW; Cheng YC; Schabel FM; Montgomery JA
    Cancer Res; 1980 Oct; 40(10):3610-5. PubMed ID: 6254636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic action of 5-aza-2'-deoxycytidine and 3-deazauridine on L1210 leukemic cells and EMT6 tumor cells.
    Momparler RL; VeselĂ˝ J; Momparler LF; Rivard GE
    Cancer Res; 1979 Oct; 39(10):3822-7. PubMed ID: 476619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased resistance to gemcitabine (2',2'-difluorodeoxycitidine) of cytosine arabinoside-resistant myeloblastic murine and rat leukemia cell lines: role of altered activity and substrate specificity of deoxycytidine kinase.
    Bergman AM; Pinedo HM; Jongsma AP; Brouwer M; Ruiz van Haperen VW; Veerman G; Leyva A; Eriksson S; Peters GJ
    Biochem Pharmacol; 1999 Feb; 57(4):397-406. PubMed ID: 9933028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of differentiation of acute promyelocytic leukemia cells by a cytidine deaminase-resistant analogue of 1-beta-D-arabinofuranosylcytosine, 1-(2-deoxy-2-methylene-beta-D-erythro-pentofuranosyl)cytidine.
    Niitsu N; Ishii Y; Matsuda A; Honma Y
    Cancer Res; 2001 Jan; 61(1):178-85. PubMed ID: 11196157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of in vitro and in vivo effects of thymidine on L1210 leukemia in mice.
    Zaharko DS; Ramonas LM
    J Natl Cancer Inst; 1982 May; 68(5):875-80. PubMed ID: 6951095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substrate-specific deoxycytidine kinase deficiency in 1-beta-D-arabinofuranosylcytosine-resistant leukemic cells.
    Richel DJ; Colly LP; Arkesteijn GJ; Arentsen-Honders MW; Kerster MG; ter Riet PM; Willemze R
    Cancer Res; 1990 Oct; 50(20):6515-9. PubMed ID: 2208110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complementary antineoplastic activity of the cytosine nucleoside analogues troxacitabine (Troxatyl) and cytarabine in human leukemia cells.
    Bouffard DY; Jolivet J; Leblond L; Hamelin B; Ouellet F; Barbeau S; Richard A; Gourdeau H
    Cancer Chemother Pharmacol; 2003 Dec; 52(6):497-506. PubMed ID: 12955470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased sensitivity of thymidine kinase-deficient (TK-) tumor cell lines to the cell growth inhibitory effects of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and related compounds.
    Balzarini J; De Clercq E; Verbruggen A; Crumpacker C; Ayusawa D; Seno T
    Anticancer Res; 1986; 6(5):1077-84. PubMed ID: 2432829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antileukemic activity of sulfonamide conjugates of arabinosylcytosine.
    Novotny L; Phillips OA; Rauko P; Miadokova E
    Exp Oncol; 2006 Dec; 28(4):293-8. PubMed ID: 17285113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retroviral transfer of deoxycytidine kinase into tumor cell lines enhances nucleoside toxicity.
    Hapke DM; Stegmann AP; Mitchell BS
    Cancer Res; 1996 May; 56(10):2343-7. PubMed ID: 8625309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased activation of 1-beta-D-arabinofuranosylcytosine by hydroxyurea in L1210 cells.
    Walsh CT; Craig RW; Agarwal RP
    Cancer Res; 1980 Sep; 40(9):3286-92. PubMed ID: 7427943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion mutants of human deoxycytidine kinase mRNA in cells resistant to antitumor cytosine nucleosides.
    Obata T; Endo Y; Tanaka M; Uchida H; Matsuda A; Sasaki T
    Jpn J Cancer Res; 2001 Jul; 92(7):793-8. PubMed ID: 11473731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic competition studies of 2'-fluoro-5-iodo-1-beta-d-arabinofuranosylcytosine in vero cells and herpes simplex type 1-infected vero cells.
    Chou TC; Lopez C; Colacino JM; Feinberg A; Watanabe KA; Fox JJ; Philips FS
    Mol Pharmacol; 1984 Nov; 26(3):587-93. PubMed ID: 6092904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of deoxycytidine metabolism in vivo with high-dose thymidine in mice.
    Zaharko DS; Covey JM
    J Natl Cancer Inst; 1983 Nov; 71(5):1033-9. PubMed ID: 6580479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiproliferative activity and mechanism of action of fatty acid derivatives of arabinofuranosylcytosine in leukemia and solid tumor cell lines.
    Bergman AM; Kuiper CM; Voorn DA; Comijn EM; Myhren F; Sandvold ML; Hendriks HR; Peters GJ
    Biochem Pharmacol; 2004 Feb; 67(3):503-11. PubMed ID: 15037202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.